Evidence map›Paper›PMID 37532829›Full record

ArticleScientific reports2023

A prophylactic TXA administration effectively reduces the risk of intraoperative bleeding during open management of pelvic and acetabular fractures.

Guy Romeo Kenmegne, Chang Zou, Yixiang Lin, Yijie Yin, Shenbo Huang, Erandathie Lasanda Banneyake, Imani Savishka Gunasekera, Yue Fang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Interaction of preoperative chemoprophylaxis and tranexamic acid use does not affect transfusion in acetabular fracture surgery.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guy Romeo Kenmegne *Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Chang Zou *Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yixiang LinDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yijie YinDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Shenbo HuangDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Erandathie Lasanda BanneyakeDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Imani Savishka GunasekeraDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yue FangDepartment of Orthopedics, West China Hospital of Sichuan University, Chengdu, 610041, China. fangyue1968@163.com.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the efficacy of perioperative intravenous TXA in reducing blood loss in pelvic and acetabular fracture patients managed surgically. The study included 306 consecutive patients, divided as: group I, 157 patients who did not receive perioperative infusion of TXA and group II, 149 patients who received perioperative TXA. The perioperative blood test results and complication rates were compared between the two groups. The average perioperative hematocrit was higher during the preoperative period than during the first, second and third postoperative day in both groups. In the estimated blood loss between the two groups, there was a significant difference of 1391 (± 167.49) ml in group I and 725 (± 403.31) ml in group II respectively (p = 0.02). No significant difference was seen in the total of intraoperative transfusion units as well as in the total units of blood transfused. There was a reduced level of postoperative hemoglobin (9.28 ± 17.88 g/dl in group I and 10.06 ± 27.57 g/dl in group II compared to the values obtained in preoperative investigations (10.4 ± 2.37 g/dl in group I and 11.4 ± 2.08 g/dl in group II); with a significant difference in postoperative transfusion rates (p = 0.03). Therefore, the use of TXA effectively reduces the risk of intraoperative bleeding during open management of pelvic and acetabular fractures.

Indexed as

Antifibrinolytic AgentsHip FracturesTranexamic AcidAdministration, IntravenousBlood Loss, SurgicalBlood TransfusionHumansRetrospective StudiesAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID37532829
PMCPMC10397234
OpenAlexW4385480994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.